Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 4
A Multi-Centre Non-Inferiority Randomized Controlled Trial of STOPping Cardiac MEDications in Patients With Normalized Cancer Therapy Related Cardiac Dysfunction: The STOP-MED CTRCD Trial
Cancer therapy-related cardiac dysfunction (CTRCD) is when the heart's ability to pump oxygenated blood to the body is compromised. It is a side effect of canc…
Heart FailureCardiotoxicityCardiac Toxicity+2 more
Dinesh ThavendiranathanNCT06183437
Phase 2
STACIE: Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted Therapy
This study proposes that the addition of statins reduces the treatment delays or early discontinuations secondary to cardiotoxicity in patients with Stage I-II…
Cardiac ToxicityEarly-stage Breast Cancer
Rutgers, The State University of New JerseyNCT05559164